@article{c365b071ee78476aabed2ee972c153bf,
title = "Phase I clinical trial of the intraperitoneal (IP) administration of a novel nanoparticle formulation of paclitaxel (NTX).",
author = "Williamson, \{Stephen K.\} and Jo Wick and Chapman, \{Julia A.\} and Gary Johnson and Greg Reed and Schulz, \{Thomas K.\} and Holly Smith and Scott Weir and Decedue, \{Charles J\} and Jahna Howell and Katherine Roby",
note = "2558 Background: IP therapy is an attractive option for patients with IP carcinomatosis as many of these malignancies remain confined IP. Agents whose plasma clearance rates substantially exceed their rates of uptake from the peritoneal cavity are especially suited for IP administration.",
year = "2013",
month = may,
day = "20",
doi = "10.1200/JCO.2013.31.15\_SUPPL.2558",
language = "American English",
volume = "31",
journal = "Journal of Clinical Oncology",
}